Home Journals Articles Updates About
CN
image
收藏切换
To explore the quality markers of Huangqin Qingre Chubi capsule in the treatment of rheumatoid arthritis based on network pharmacology combined with pharmacokinetics and target verification
收藏切换
PDF
Xin-tong DONG1, Jiang-tao KE1, Pei-rong GAN1, Fang-yuan CHEN1, Feng XU2, Jian CHEN3, Jian LIU4, *, Hong WU1, *
Acta Pharmaceutica Sinica | 2023, 58(6) : 1422 - 1429
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(6): 1422-1429
• Special Reports: Research on Modernization of Traditional Chinese Medicine Based on Integrative Pharmacology •
To explore the quality markers of Huangqin Qingre Chubi capsule in the treatment of rheumatoid arthritis based on network pharmacology combined with pharmacokinetics and target verification
Full
Xin-tong DONG1, Jiang-tao KE1, Pei-rong GAN1, Fang-yuan CHEN1, Feng XU2, Jian CHEN3, Jian LIU4, *, Hong WU1, *
Affiliations
  • 1. School of Pharmacy, Anhui University of Chinese Medicine, Key Lab of Xin'an Medicine, Ministry of Education, Anhui Province Key Laboratory of Research and Development of Chinese Medicine, Hefei 230012, China
  • 2. The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
  • 3. School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
  • 4. The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
Published: 2023-06-12 doi: 10.16438/j.0513-4870.2022-1447
Outline
收藏切换

As an effective prescription for the treatment of rheumatoid arthritis (RA), Huangqin Qingre Chubi capsule (HQC) is still blank in quality control. This study aims to explore quality markers (Q-markers) for HQC in the treatment of RA by integrating network pharmacology and pharmacokinetics. By constructing the visualization network of "pharmacodynamic ingredient-target-pathway", the potential Q-Marker of HQC treatment for RA was preliminatively predicted. A rat model of rheumatic heat obstruction syndrome collagene-induced arthritis (CIA) was established to elucidate the dynamic quantification law of pharmacodynamic components of HQC in the disease state of rats. To establish the inflammatory model of RA synovial fibroblasts (MH7A) induced by tumor necrosis factor-α (TNF-α) in vitro. The effects of active ingredients on protein expression of sphingosin kinase-1 (Sphk1) and p-SphK1 were detected. The network pharmacological results showed that baicalin, geniposide, luteolin, coixol and amygdalin were the important active components of HQC treatment for RA. Quantitative analysis results further verified the measurability of these five components. The expression of Sphk1 and p-SphK1 was significantly inhibited by geniposide and baicalin by Western blotting. The above studies determined that the above 5 components could be used as Q-markers in the treatment of RA by HQC. This experiment was approved by the Experimental Animal Ethics Committee of Anhui University of Chinese Medicine (approval number: AHUCM-rats-2021049). All procedures were conducted in strict accordance with the principles of animal use and care.

rheumatoid arthritis  /  quality marker  /  Huangqin Qingre Chubi capsule  /  heat arthralgia  /  network pharmacology  /  pharmacokinetics
Xin-tong DONG, Jiang-tao KE, Pei-rong GAN, Fang-yuan CHEN, Feng XU, Jian CHEN, Jian LIU, Hong WU. To explore the quality markers of Huangqin Qingre Chubi capsule in the treatment of rheumatoid arthritis based on network pharmacology combined with pharmacokinetics and target verification[J]. Acta Pharmaceutica Sinica, 2023 , 58 (6) : 1422 -1429 . DOI: 10.16438/j.0513-4870.2022-1447
Appendix
Less
Year 2023 volume 58 Issue 6
PDF
162
61
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-1447
  • Receive Date：2022-12-31
  • Online Date：2025-11-21
  • Published：2023-06-12
Article Data
Affiliations
History
  • Received：2022-12-31
  • Revised：2023-04-23
Funding
Affiliations
    1. School of Pharmacy, Anhui University of Chinese Medicine, Key Lab of Xin'an Medicine, Ministry of Education, Anhui Province Key Laboratory of Research and Development of Chinese Medicine, Hefei 230012, China
    2. The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
    3. School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
    4. The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-1447
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House